RMTI (Rockwell Medical) Total Equity: $35.86 Mil (As of Mar. 2026)


RMTI Rockwell Medical Inc RMTI
26 GF Score
Price $5.54
GF Value $0.95
Valuation Significantly Overvalued
! 3 Warning Signs
View Full Analysis

What is Rockwell Medical Total Equity?

Rockwell Medical RMTI +6.74% 26 Total Equity is $35.86 Mil as of Mar. 2026. GuruFocus rates RMTI with a GF Score™ of 26/100 and a GF Value™ of $0.95 (Significantly Overvalued). The stock has 3 warning signs investors should review.

Rockwell Medical's total equity for the quarter that ended in Mar. 2026 was $35.86 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.

Rockwell Medical Total Equity Historical Data

* Premium members only.

The historical data trend for Rockwell Medical's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Rockwell Medical Total Equity Chart

Rockwell Medical Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.54 14.11 21.29 32.59 36.98

Rockwell Medical Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Total Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 31.52 30.41 37.02 36.98 35.86
RMTI
26GF Score
Rockwell Medical Inc RMTI
Total Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Rockwell Medical Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

Rockwell Medical's Total Equity for the fiscal year that ended in Dec. 2025 is calculated as

Total Equity=Total Assets(Q: Dec. 2025 )-Total Liabilities(Q: Dec. 2025 )
=57.145-20.164
=36.98

Rockwell Medical's Total Equity for the quarter that ended in Mar. 2026 is calculated as

Total Equity=Total Assets(Q: Mar. 2026 )-Total Liabilities(Q: Mar. 2026 )
=57.423-21.566
=35.86

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Equity →
What does a Total Equity of $35.86 Mil mean?
Rockwell Medical (RMTI) has a Total Equity of $35.86 Mil as of Mar. 2026. The total amount of equity as record on a company's balance sheet. View historical data for Rockwell Medical and its competitors.
Is Rockwell Medical's Total Equity too high?
Rockwell Medical's current Total Equity is $35.86 Mil. Overall, Rockwell Medical has a GF Score™ of 26/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Rockwell Medical's Total Equity compare to CPHI and TXMD?
Rockwell Medical's Total Equity of $35.86 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Equity for a Drug Manufacturers company?
A good Total Equity depends on the Drug Manufacturers industry context. However, Total Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Equity mean?
A high Total Equity can signal that a stock is expensive relative to its fundamentals. The total amount of equity as record on a company's balance sheet. View historical data for Rockwell Medical and its competitors. Rockwell Medical's current Total Equity is $35.86 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Rockwell Medical stock overvalued right now?
Based on GuruFocus' analysis, Rockwell Medical (RMTI) is currently considered Significantly Overvalued. The stock's GF Value™ is $0.95, compared to a current price of $5.54 — trading 483.2% above its estimated fair value. The current Total Equity is $35.86 Mil. Rockwell Medical's overall GF Score™ is 26/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Equity calculated?
Total Equity is calculated from a company's financial statements. For Rockwell Medical (RMTI), the current Total Equity is $35.86 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Rockwell Medical (RMTI) Overvalued in 2026?

Based on GuruFocus' analysis, Rockwell Medical stock appears to be overvalued. The current stock price of $5.54 is trading 483.2% above its estimated GF Value™ of $0.95. GuruFocus considers Rockwell Medical to be Significantly Overvalued.

Key valuation signals for RMTI:

  • Total Equity: $35.86 Mil
  • GF Value™: $0.95 vs. price of $5.54 (483.2% above fair value)
  • GF Score™: 26/100 with 3 warning signs

No single metric tells the full story. See the RMTI stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Rockwell Medical Business Description

Other Exchanges RWMA:Germany
Address 30142 South Wixom Road, Wixom, MI, USA, 48393
Rockwell Medical Inc is a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products for dialysis providers. It is a supplier of liquid bicarbonate concentrates, acid, and dry bicarbonate concentrates for dialysis patients in the United States. The company's products include CitraPure citric acid concentrate, RenalPure liquid acid concentrate, and SteriLyte bicarbonate concentrate, among others. The company delivers the majority of its hemodialysis concentrates products and mixers to dialysis clinics throughout the United States and internationally, utilizing its own delivery trucks and third-party carriers.
26GF Score

Get the complete analysis for RMTI

Total Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$5.54
Price
$0.95
GF Value